Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06577311 · ClinicalTrials.gov registry record · Phase 2
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
A Phase 2 study of Cutaneous Squamous Cell Carcinoma, sponsored by The Center for Clinical and Cosmetic Research.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06577311 is a Phase 2 study of Cutaneous Squamous Cell Carcinoma that is actively recruiting participants, run by The Center for Clinical and Cosmetic Research. The registered enrollment target is 20 participants, below the 91-participant average among 18 other Cutaneous Squamous Cell Carcinoma trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06577311, a Phase 2 study of Cutaneous Squamous Cell Carcinoma, is actively recruiting participants, sponsored by The Center for Clinical and Cosmetic Research.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive gel used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laboratory testing, how much of the affected facial skin cancer section the treatment was able to remove, and; * seeing how many participants had no remaining affected facial skin cancer sections after treatment. Participants who qualify will be asked to complete 14 visits in total and will receive a total of two treatments, after voluntarily consent has been given.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Aminolevulinic acid hydrochloride 10% topical gel with Red Light
Study Locations (1)
Florida
- Center for Clinical and Cosmetic Research - Aventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2025-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06577311
The ClinicalTrials.gov registry entry for NCT06577311 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 18 other Cutaneous Squamous Cell Carcinoma trials with a reported enrollment target (78% lower). The listed sponsor is The Center for Clinical and Cosmetic Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cutaneous Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Aminolevulinic acid hydrochloride 10% topical gel with Red Light is the first listed.
NCT06577311 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06577311 about?
NCT06577311 is a clinical study titled "Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)". The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive gel used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laborator...
What is the current status of trial NCT06577311?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2024-08-14. Estimated completion is 2025-08.
What conditions does trial NCT06577311 study?
This clinical trial studies the following conditions: Cutaneous Squamous Cell Carcinoma.
What interventions are being tested in trial NCT06577311?
The interventions under investigation include: Aminolevulinic acid hydrochloride 10% topical gel with Red Light (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06577311?
This trial is sponsored by The Center for Clinical and Cosmetic Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06577311 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIL Therapy in cSCC and MCC
RECRUITING · Phase 2
-
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
COMPLETED · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.